United Kingdom Transient Ischaemic Attack Aspirin Trial "UK-TIA"

Completed

Phase N/A Results

Summary of Purpose

To compare the relative efficacies of two different doses of aspirin taken daily on a long-term basis in the secondary prevention of stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 30 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Medical Research Council, Beecham Products, Eli Lilly, Evans Medical/Glaxo, Wasell Packaging, Aspirin Foundation

Trial Design

Randomized, double-blind, placebo-controlled trial of 2435 patients at 33 centers.

Contacts

Not available